if you become pregnant whilst on treatment, stop the medication and seek immediate medical and nutritional review [1] [25] Contact your GP urgently if you experience: Severe, persistent abdominal pain (with or without vomiting) which could indicate pancreatitis Upper-right abdominal pain, fever or jaundice which may suggest gallbladder disease Persistent nausea or vomiting preventing adequate nutrition Signs of dehydration (dark urine, dizziness, reduced urination) Unexplained symptoms such as jaundice, severe fatigue, or mood changes For people with diabetes: hypoglycaemia (low blood sugar) symptoms when taking insulin or sulfonylureas alongside GLP-1 therapy Regular monitoring throughout GLP-1 treatment should include periodic assessment of weight, body composition where possible, nutritional intake, and relevant blood markers
Semaglutide 3 mg is one of the popular meds that form part of a sub-category called peptide-1 receptor agonist meds
Your endocrinologist needs to know about GLP-1 dose changes and weight milestones
Bttinger L, Horvath SE, Kleinschroth T et al (2012) Phosphatidylethanolamine and Cardiolipin differentially affect the stability of mitochondrial respiratory chain supercomplexes
This means each 0.1mL (10 units on a U-100 insulin syringe) contains 0.5mg of semaglutide
This also causes their initial side effects, such as nausea, diarrhea, constipation, and vomiting